Diabetes News You Can Use

Study: Clinical trial participants say sharing health data is beneficial

Eighty-one percent and more than 85% of 771 surveyed clinical trial participants reported that data sharing would benefit physicians and scientists, respectively, according to a study in The New England Journal of Medicine. Less than 10% of respondents reported being “very” concerned about the possible consequences of data sharing, while less than a third expressed being “very” or “somewhat” concerned about the potential risks, including the possibility of their information being hacked or used for poor-quality research.

EHR Intelligence (6/8)

Insulin levels stabilize after 7 years of annual declines, study finds

A study in Diabetes Care showed that insulin levels decline by nearly 50% every year for seven years in type 1 diabetes patients, but stabilize thereafter. UK researchers evaluated 1,549 type 1 diabetes patients and said the findings indicate patients will keep any remaining working beta-cells seven years after diagnosis, which could lead to new therapies.
Diabetes (UK) (6/8)

Dual-hormone system tied to reduced hypoglycemia in diabetes, study finds

Type 1 diabetes patients who used a dual-hormone system, which includes adding glucagon delivery to a closed-loop system using wearable sensors, during moderate-intensity aerobic exercise sessions had the lowest time in hypoglycemia and lowest mean time in hypoglycemia, compared with using a single-hormone system, predictive low glucose suspend or current care, according to a study in Diabetes Care. Researchers used a cohort of 20 patients and found that the time in range was higher with the single-hormone group than the dual-hormone group.

Physician’s Briefing/HealthDay News (5/15) 

ADA leads effort to demand insulin pricing transparency

Several stakeholders from the diabetes community, including the American Diabetes Association, asked legislators with the Senate Special Committee on Aging for help regarding transparency with the increasing prices of insulin. The ADA’s insulin access and affordability working group released a consensus statement, published in Diabetes Care, that identified the factors influencing insulin prices and highlighted the difference between the list price and “net” price of insulin, noting the lack of data that outlines the differences.

Healio (free registration)/Endocrine Today (5/8)

Study links antipsychotic drugs to gestational diabetes risk

Pregnant women who took the antipsychotics olanzapine or quetiapine were at higher risk of gestational diabetes than those who stopped treatment during pregnancy, according to a study published in The American Journal of Psychiatry and presented at the American Psychiatric Association’s annual meeting. Women who continued the drugs while pregnant had greater comorbidity and longer antipsychotic use.

Healio (free registration)/Psychiatric Annals (5/7)

Upcoming Events

Warning: Use of undefined constant ASC - assumed 'ASC' (this will throw an Error in a future version of PHP) in /nfs/bronfs/uwfs/hw00/d49/diabetes/wp-content/themes/uwdrc/page-home.php on line 36
The Diabates and Metabolism Seminar Series will resume in the Fall.

Other Events

Warning: Use of undefined constant ASC - assumed 'ASC' (this will throw an Error in a future version of PHP) in /nfs/bronfs/uwfs/hw00/d49/diabetes/wp-content/themes/uwdrc/page-home.php on line 69